OncoMark wins award at industry event in Brussels!
Mr Des O'Leary, OncoMark's CEO, pitched to an audience of CEOs from more than 400 SMEs from around Europe. The pitch, focusing on our novel OncoMasTR assay for early stage breast cancer, received the award for the best pitch in Health at the SME Instrument Innovators Summit, held in Brussels on 10th-11th October 2016.
OncoMasTR will reduce the number of early stage breast cancer patients receiving chemotherapy, improving patients' quality of life and reducing healthcare costs.
Mr O'Leary is pictured below (second from left) on stage with the other winners in the fields of Digital Economy and Energy.
Below, Mr O'Leary receives his award and discusses the novel OncoMasTR assay for early stage breast cancer, the innovation for which OncoMark were awarded the prestigious SME Instrument grant by the EU in 2015.